Indian CDMOs are strategically expanding through acquisitions in the US and Europe, driven by global pharma's nearshoring ...

The tariff war the U.S. is waging against most of the world stabilized somewhat earlier this month. But let's face facts -- ...

AstraZeneca continues to impress me with the strong performances of its oncology, cardiovascular, and rare disease franchises ...

High-end medical devices, including those made in the United States, may be especially vulnerable to tariffs because they’re ...

The Liposomal Doxorubicin Market is estimated to be valued at USD 1,281.3 million in 2024. Demand is predicted to rise at a ...

GeoVax’s Advanced MVA Manufacturing Platform Supports ASPR-DARPA Vision for Scalable, AI-Integrated Pharmaceutical Production. ATLANTA, GA - May 21, 2025 (NEWMEDIAWIRE) - GeoVax ...

Merck offers a low 8.5x PE, a 4.3% yield, a robust drug pipeline, and resilient growth despite Gardasil headwinds and tariff ...

Alongside its expansion into low-scale oligo synthesis, the company has rebranded its custom oligos to better target ...

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced multiple clinical research results to be presented at the 2025 American Society of Clinical ...

The MoUs were signed individually with each partner, reflecting Globalpharma’s tailored approach to strategic collaboration.